Daewoong Pharmaceutical Reports More Than 90% Target Occupancy in Phase 1 Trial of Autoimmune Disease Drug

Courtesy of Daiwoong Pharmaceutical provided.
Courtesy of Daiwoong Pharmaceutical provided.

© Copyright by News1. All Rights Reserved.